Thank you to our Silver Level Sponsor: CareDx 👏 Learn more about CareDx® at: caredx.com #IROCFall2024Cincy

Evaluation of non-invasive biomarkers of #kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN) doi.org/10.1016/j.kint… Inserm Paris Transplant Group Université Paris Cité Assistance Publique – Hôpitaux de Paris (AP-HP) Charité - Universitätsmedizin Berlin Hôpital Necker AP-HP #OpenAccess #HLA #transplantation #transplant

EU~TRAIN large prospective multicentic 🇪🇺 trial 🧐 23 blood biomarkers -> None show association and added value to SOC for detecting rejection🚫AKR1C3 🚫CD3E🚫CD4🚫CD40🚫CD8A🚫CD9🚫CTLA4🚫FOXP3🚫GZMB🚫ID3🚫IL7R🚫MS4A1🚫MZB1, 🚫POU2F1🚫TCL1A🚫TKR4🚫TRIB1🚫AT1R🚫ETAR🚫c3AR🚫C5aR

Methodology, Context of use, adequate sample size, prospective and unselected design matter. The Eutrain EU 🇪🇺prospective study results.

La conférence internationale Banff 2024 s’est achevée vendredi 20 septembre, à l’Université Paris Cité, après avoir réuni 350 spécialistes venus du monde entier. Accueillie à Paris par le Paris Transplant Group (PITOR) de l’université Paris Cité, leader européen en matière de transplantation

Incredible discussions and inspiring dedication to advancing the field of transplant medicine. Honored to have participated #BANFF2024 #PITOR joint meeting! Université Paris Cité Académie de médecine de France Paris Transplant Group

Honored to have presented and participated in this amazing #Banff2024 meeting 🙏 Université Paris Cité Paris Transplant Group PARCC-INSERM SFNDT SFT Transplantation TTS

Speaking at the French Academy of Medicine at the start of the Banff Pre-meeting, focused on xeno-transplantation was a real honour. We aim to bring these developments to Europe ESOTtransplant Alexandre Loupy The Lancet

Glad to go to #TTS2024 in Istanbul. 🇹🇷 See you there. 😉 ⁦⁦TTS⁩ ⁦Paris Transplant Group⁩ ⁦Université Paris Cité⁩

Valentin Goutaudier shared the results of the 🇪🇺 EU-TRAIN Project Horizon Europe 🇪🇺 1️⃣recently published in Kidney International Paris Transplant Group Université Paris Cité #PITOR TTS #TTS2024 🇹🇷👇

⁦Gillian Divard⁩ is on the stage to talk about AMR treatment strategies in kidney transplant patients! #TTS2024 #Istanbul ⁦Paris Transplant Group⁩ Centre Hospitalier Saint-Louis ⁦Kevin Louis⁩

Excited to share our work released in NEJM on kidney-transplant microvascular inflammation. With data from over 16,000 biopsies, we reveal distinct rejection phenotypes linked to varied outcomes—an essential step toward standardized kidney allograft diagnostics. Paris Transplant Group

Check out our latest paper just released American Society of Nephrology #KidneyWk many thanks to all our amazing network and collaborators !

Another great collaborative work from our team just published in NEJM analyzing over 16000 biopsies including over 2500 biopsies from 1000 pediatric recipients and providing insight into microvascular inflammation in kidney allograft. Check it out 👇 x.com/NEJM/status/18…

Read our TOP CITED article of 2024 "The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics" by Naesens et al. 10.1016/j.ajt.2023.10.016

📢 Just out in Nature Communications & presented ESOTtransplant ! Our study "Impact of HLA evolutionary divergence and molecular mismatches on AMR of kidney allografts" is now published. 🔗nature.com/articles/s4146… 🙌to Zeynep Demir Carmen Lefaucheur Alexandre Loupy

There is an urgent need to expand access to life-saving transplants. On July 7, join a webinar where experts will discuss past, present, & future advances in organ transplantation. Register ➡️ hubs.li/Q03vNF380 TTS American Society of Transplantation (AST) ESOTtransplant Peter Reese

TTS American Society of Transplantation (AST) ESOTtransplant Peter Reese Explore a new Lancet Series on solid organ transplantation: hubs.li/Q03vNNCy0

Check out a new article from Zielinski et al, "Molecular diagnosis of kidney allograft rejection based on the Banff Human Organ Transplant gene panel: A multicenter international study" in the August issue of AJT! 10.1016/j.ajt.2025.04.025